E-ISSN 2149-388X | ISSN 2149-0430
 
2025, Vol: 11, Issue: 1
11 / 1Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Cover Letter
License Agreement
Title Page

Case Report 


A Rare Case Due to Intramuscular Diclofenac Injection: Necrotizing Fasciitis, Rhabdomyolysis and Acute Kidney Injury

Burak Furkan Demir, Bilal Katipoglu, Gokhan Yirgin, Ihsan Ates.


Abstract
Background: Necrotizing fasciitis which is the mortal complication of soft tissue infections due to after injection. In past, some cases were reported who had necrotizing fasciitis and rhabdomyolysis due to intramuscular and intraarticular injection. In our cases, we mention about, concurrently rhabdomyolysis and necrotizing fasciitis were seen after diclofenac drug intramuscular injection.
Case Presentation: We report herein a fatal case of progressive necrotizing fasciitis and rhabdomyolysis cause of acute kidney injury after intramuscular diclofenac injection, to the best of our knowledge, both acute kidney injury due to rhabdomyolysis and necrotizing fasciitis after intramuscular diclofenac injection are reported for the first time in this case.

Key words: Acute kidney injury, diclofenac, intramuscular injection, necrotizing fasciitis,rhabdomyolysis,


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Burak Furkan Demir
Articles by Bilal Katipoglu
Articles by Gokhan Yirgin
Articles by Ihsan Ates
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Demir BF, Katipoglu B, Yirgin G, Ates I. A Rare Case Due to Intramuscular Diclofenac Injection: Necrotizing Fasciitis, Rhabdomyolysis and Acute Kidney Injury. Ulutas Med J. 2018; 4(1): 50-52. doi:10.5455/umj.20180207122003

Web Style

Demir BF, Katipoglu B, Yirgin G, Ates I. A Rare Case Due to Intramuscular Diclofenac Injection: Necrotizing Fasciitis, Rhabdomyolysis and Acute Kidney Injury. https://www.ulutasmedicaljournal.com/?mno=290455 [Access: March 15, 2025]. doi:10.5455/umj.20180207122003

AMA (American Medical Association) Style

Demir BF, Katipoglu B, Yirgin G, Ates I. A Rare Case Due to Intramuscular Diclofenac Injection: Necrotizing Fasciitis, Rhabdomyolysis and Acute Kidney Injury. Ulutas Med J. 2018; 4(1): 50-52. doi:10.5455/umj.20180207122003


Vancouver/ICMJE Style

Demir BF, Katipoglu B, Yirgin G, Ates I. A Rare Case Due to Intramuscular Diclofenac Injection: Necrotizing Fasciitis, Rhabdomyolysis and Acute Kidney Injury. Ulutas Med J. (2018), [cited March 15, 2025]; 4(1): 50-52. doi:10.5455/umj.20180207122003


Harvard Style

Demir, B. F., Katipoglu, . B., Yirgin, . G. & Ates, . I. (2018) A Rare Case Due to Intramuscular Diclofenac Injection: Necrotizing Fasciitis, Rhabdomyolysis and Acute Kidney Injury. Ulutas Med J, 4 (1), 50-52. doi:10.5455/umj.20180207122003


Turabian Style

Demir, Burak Furkan, Bilal Katipoglu, Gokhan Yirgin, and Ihsan Ates. 2018. A Rare Case Due to Intramuscular Diclofenac Injection: Necrotizing Fasciitis, Rhabdomyolysis and Acute Kidney Injury. THE ULUTAS MEDICAL JOURNAL, 4 (1), 50-52. doi:10.5455/umj.20180207122003


Chicago Style

Demir, Burak Furkan, Bilal Katipoglu, Gokhan Yirgin, and Ihsan Ates. "A Rare Case Due to Intramuscular Diclofenac Injection: Necrotizing Fasciitis, Rhabdomyolysis and Acute Kidney Injury." THE ULUTAS MEDICAL JOURNAL 4 (2018), 50-52. doi:10.5455/umj.20180207122003


MLA (The Modern Language Association) Style

Demir, Burak Furkan, Bilal Katipoglu, Gokhan Yirgin, and Ihsan Ates. "A Rare Case Due to Intramuscular Diclofenac Injection: Necrotizing Fasciitis, Rhabdomyolysis and Acute Kidney Injury." THE ULUTAS MEDICAL JOURNAL 4.1 (2018), 50-52. Print. doi:10.5455/umj.20180207122003


APA (American Psychological Association) Style

Demir, B. F., Katipoglu, . B., Yirgin, . G. & Ates, . I. (2018) A Rare Case Due to Intramuscular Diclofenac Injection: Necrotizing Fasciitis, Rhabdomyolysis and Acute Kidney Injury. THE ULUTAS MEDICAL JOURNAL, 4 (1), 50-52. doi:10.5455/umj.20180207122003


Author LoginReviewer LoginAbout PublisherOpen Access PolicyEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About THE ULUTAS MEDICAL JOURNAL

The Ulutas Medical Journal (UMJ) is a 3 monthly (quarterly), open access, double-blind peer-reviewed, an international journal. Writing a research pap ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Journal Owner
HAYRİYE ZEHRA ULUTAŞ
Phone: +90 (532) 165 96 39​
E-mail: zehrakenanoglu@hotmail.com​
Address: Alaattin Mah. 30. Ada sok. D11 Blok
No:4 Gungor Uydukent Sitesi  Antakya/HATAY

Editor-In-Chief
KEMAL TURKER ULUTAS, MD, Assc. Prof.
Phone: + 90 (555) 491 35 59​
E-mail: drkemalturker@gmail.com
Address: Alaattin Mah. 30. Ada sok. D11 Blok
No:4 Gungor Uydukent Sitesi  Antakya/HATAY

Publisher Information
SCOPEMED Publishing Co. - TURKEY​
E-mail: scopemed@scopemed.org
Web: https://www.scopemed.com/

 

We welcome your submissions, suggestions, comments, or questions. To reach us, please use one of the methods provided on this page or Email us at ulutasmedicaljournal@gmail.com​

We will respond within 48 to 72 hours.